We are live on ! Find out more
AACP

Advantage Alpha Capital Partners Portfolio holdings

AUM $332M
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$439M
AUM Growth
-$18.9M
Cap. Flow
-$58.7M
Cap. Flow %
-13.36%
Top 10 Hldgs %
18.42%
Holding
197
New
43
Increased
53
Reduced
70
Closed
31

Top Buys

Rank Stock Value
1
WMS icon
Advanced Drainage Systems
WMS
+$8.48M
2
GTLS
Chart Industries
GTLS
+$6.28M
3
HUBS icon
HubSpot
HUBS
+$4.98M
4
FAF icon
First American
FAF
+$4.75M
5
CNM icon
Core & Main
CNM
+$4.46M

Top Sells

Rank Stock Value
1
LKQ icon
LKQ Corp
LKQ
+$11.9M
2
VRNS icon
Varonis Systems
VRNS
+$5.56M
3
APPN icon
Appian
APPN
+$5.1M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$4.83M
5
SN icon
SharkNinja
SN
+$4.42M

Sector Composition

Rank Sector Weight
1 Industrials 33.93%
2 Technology 20.57%
3 Healthcare 11.93%
4 Financials 10.79%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
151
Acadia Pharmaceuticals
ACAD
$5.02B
$383K 0.09%
24,914
-13,160
-35% -$220K
MDGL icon
152
Madrigal Pharmaceuticals
MDGL
$12.3B
$349K 0.08%
+1,643
New +$420K
ANIP icon
153
ANI Pharmaceuticals
ANIP
$1.67B
$344K 0.08%
+5,772
New +$352K
GH icon
154
Guardant Health
GH
$21.7B
$343K 0.08%
+14,937
New +$423K
COLL icon
155
Collegium Pharmaceutical
COLL
$786M
$341K 0.08%
+8,813
New +$314K
GYRE icon
156
Gyre Therapeutics
GYRE
$699M
$334K 0.08%
+26,634
New +$343K
CSTL icon
157
Castle Biosciences
CSTL
$1.02B
$312K 0.07%
+10,940
New +$278K
ORGO icon
158
Organogenesis Holdings
ORGO
$224M
$290K 0.07%
101,558
-256,896
-72% -$720K
PSTX
159
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$285K 0.06%
+99,566
New +$308K
PBYI icon
160
Puma Biotechnology
PBYI
$468M
$276K 0.06%
+108,129
New +$327K
SIGA icon
161
SIGA Technologies
SIGA
$220M
$276K 0.06%
+40,841
New +$357K
FENC icon
162
Fennec Pharmaceuticals
FENC
$430M
$264K 0.06%
+52,876
New +$306K
DH icon
163
Definitive Healthcare
DH
$85.7M
$262K 0.06%
58,505
-363,941
-86% -$1.71M
IBRX icon
164
ImmunityBio
IBRX
$8.53B
$257K 0.06%
+69,207
New +$320K
CLYM
165
Climb Bio
CLYM
$837M
$245K 0.06%
+48,169
New +$341K
HBIO icon
166
Harvard Bioscience
HBIO
$36.1M
$63.5K 0.01%
+2,362
New +$69.6K
ACA icon
167
Arcosa
ACA
$7.13B
– –
-5,518
Closed -$460K
AGL icon
168
Agilon Health
AGL
$1.55B
– –
-14,559
Closed -$2.38M
APA icon
169
APA Corp
APA
$14.9B
– –
-13,262
Closed -$390K
ARCT icon
170
Arcturus Therapeutics
ARCT
$432M
– –
-27,040
Closed -$658K
BOOT icon
171
Boot Barn
BOOT
$4.69B
– –
-20,398
Closed -$2.63M
CDRE icon
172
Cadre Holdings
CDRE
$1.32B
– –
-70,517
Closed -$2.37M
CHH icon
173
Choice Hotels
CHH
$4.9B
– –
-24,079
Closed -$2.87M
CHRD icon
174
Chord Energy
CHRD
$7.99B
– –
-2,529
Closed -$424K
CIVI
175
DELISTED
Civitas Resources
CIVI
– –
-5,924
Closed -$409K
4 5 6
7
8

Similar funds

CPA
Court Place Advisors Ellicott City, Maryland $332M AUM 16.16% 1-Year Est. Return
PAWA
Palo Alto Wealth Advisors Palo Alto, California $343M AUM 33.47% 1-Year Est. Return
EE
EWG Elevate Roseville, California $320M AUM 18.11% 1-Year Est. Return
GB
Gunma Bank Gunma, Japan $319M AUM 1.17% 1-Year Est. Return
SC
Solari Capital Palm Beach Gardens, Florida $318M AUM
SFG
Sterling Financial Group Pasadena, California $316M AUM 10.54% 1-Year Est. Return
PA
Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return
BCCM
Bridge Creek Capital Management West Barnstable, Massachusetts $360M AUM 16.27% 1-Year Est. Return

Advantage Alpha Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Advantage Alpha Capital Partners held 197 positions worth $439M, down 4.1% from $458M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Advantage Alpha Capital Partners withdrew a net $58.7M in Q3 2024, closing 31 positions and reducing 70 holdings. Its most notable exit was LKQ Corp, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advantage Alpha Capital Partners opened a new position in Advanced Drainage Systems worth $8.54M.

  • Advantage Alpha Capital Partners's largest Q3 2024 buy was Advanced Drainage Systems: 54,341 shares worth $8.54M.
  • Advantage Alpha Capital Partners added most to HubSpot in Q3 2024, an estimated $4.98M increase.
  • Advantage Alpha Capital Partners's biggest Q3 2024 reduction was Varonis Systems, cutting an estimated $5.56M.
  • Advantage Alpha Capital Partners fully exited LKQ Corp in Q3 2024, selling an estimated $11.9M.
  • Advantage Alpha Capital Partners's ten largest holdings make up 18% of its $439M portfolio in Q3 2024.
  • Advantage Alpha Capital Partners opened 43 new positions and closed 31 in Q3 2024.
  • Advantage Alpha Capital Partners's portfolio value fell 4.1% quarter-over-quarter to $439M.

Based on Advantage Alpha Capital Partners's 13F filing for Q3 2024, filed 13 Nov 2024.